望星薬局における薬歴データを利用した降圧薬の使用実態研究

Saved in:
Bibliographic Details
Published in薬剤疫学 Vol. 1; no. 2; pp. 107 - 115
Main Authors 浜田, 知久馬, 楠, 正, 石倉, 千代治, 三溝, 和男
Format Journal Article
LanguageJapanese
Published 一般社団法人 日本薬剤疫学会 1996
Online AccessGet full text
ISSN1342-0445
1882-790X
DOI10.3820/jjpe1996.1.107

Cover

Author 楠, 正
三溝, 和男
浜田, 知久馬
石倉, 千代治
Author_xml – sequence: 1
  fullname: 浜田, 知久馬
  organization: 東京大学医学部薬剤疫学
– sequence: 1
  fullname: 楠, 正
  organization: 東京大学医学部薬剤疫学
– sequence: 1
  fullname: 石倉, 千代治
  organization: 望星薬局
– sequence: 1
  fullname: 三溝, 和男
  organization: 望星薬局
BookMark eNo9UEtLw0AYXKSCtfbqv0jdV7qboxZfUPBSwVvYZDfaUGtJevFmWsRi8aAUH1ioNy1qQRBPSn_MmlT_hYGqh5lvmBm-w8yDTP2grgBYRLBAOIZLvt9QyLKKBVRAkM2ALOIcG8yCO5lUE4oNSKk5B_JhWHUgxJRThkgWVJL-bXI9-Lp8il-OdPSoo1MdnetWN3WS51fdPtHtd90a69ZF3BlOeg86utLR4PvmLO7fpx0djT4_xqkfjwbJcXdy15sM3xbArCdqocr_3hzYXlutlDaM8tb6Zmm5bPjYhNCgjCCPK1GkGLpUSuwSB7tF4jGmJIQe5Vg4nFoSKocKVzKFqFTUMWXKJnVIDqxM__phU-wquxFU90VwaIugWXVryv4bxUY2ngKy_9DdE4HtC_IDzJB9hw
ContentType Journal Article
Copyright 日本薬剤疫学会
Copyright_xml – notice: 日本薬剤疫学会
DOI 10.3820/jjpe1996.1.107
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1882-790X
EndPage 115
ExternalDocumentID article_jjpe1996_1_2_1_2_107_article_char_ja
GroupedDBID ABJNI
ACGFS
ALMA_UNASSIGNED_HOLDINGS
CS3
JSF
KQ8
RJT
ID FETCH-LOGICAL-j2500-4731f8ea6420c4dd2c3b2c63f77ed00f482ab849d0eb4acd7e14de4b5dde454b3
ISSN 1342-0445
IngestDate Wed Sep 03 06:30:41 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Issue 2
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j2500-4731f8ea6420c4dd2c3b2c63f77ed00f482ab849d0eb4acd7e14de4b5dde454b3
OpenAccessLink https://www.jstage.jst.go.jp/article/jjpe1996/1/2/1_2_107/_article/-char/ja
PageCount 9
ParticipantIDs jstage_primary_article_jjpe1996_1_2_1_2_107_article_char_ja
PublicationCentury 1900
PublicationDate 19960000
PublicationDateYYYYMMDD 1996-01-01
PublicationDate_xml – year: 1996
  text: 19960000
PublicationDecade 1990
PublicationTitle 薬剤疫学
PublicationTitleAlternate 薬剤疫学
PublicationYear 1996
Publisher 一般社団法人 日本薬剤疫学会
Publisher_xml – name: 一般社団法人 日本薬剤疫学会
References 1) 酒井弘憲, 林 邦彦, 折笠秀樹, 楠正.高血圧薬物治療指針の背景と長期臨床比較試験の役割.臨床薬理1995;26 : 637-50.
7) Report of a WHO Expert Committee. Arterial Hypertension Technical Report Series No. 628. Geneva : WHO 1978.
18) Kaplan NM. Clinical Hypertension, 6th ed. 1994 : 198.
16) Wertheimer AI.Defined daily dose (DDD) system for drug utilization review. Hosp Pharrn 1986 ; 21 : 233-4.
10) 厚生省・日本医師会, 編.薬物療法.高血圧診療のてびき.日本医事新報社, 1990 : 24-36
23) Furberg CD, Psaty BM, Meyer JV. Nifedipine ; Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995 ; 92 : 1326-31.
20) Murakami M, Murakami E, Takekoshi N, et al. Antihypertensive effect of (4-2'-nitrophenyl) -2, 6-dimethyl-1, 4-dihydropyridine-3, 5-dicarbonic acid dimethyl-ester (nifedipine, Bay-a 1040), a new coronary dilator. Jpn Heart J 1972 ; 13 : 128-36.
17) WHO Collaborating Center for Drug Statistics Methodology. Guidelines for DDD 2nd ed. 1993, Oslo : 1993 : 1-95.
24) Burning JE, Glynn RJ, Hennekens CH. Calcium channel blockers and myocardial infarction ; A Hypothesis formulated but not yet tested. JAMA 1995 ; 274 : 654-5.
21) 池田正男, 青木久三, 荒川規男ほか. Diltiazem (Herbesser) の本態性高血圧症に対する臨床効果.医学のあゆみ1979;110 : 302-20.
2) The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Report of the joint national committee on detection, evaluation, and treatment of high blood pressure. JAMA 1977 ; 237 (3) : 255-61.
14) 田中照夫, 市原和彦, 西岡豊ほか.四国地区の国立四大学附属病院における降圧薬の服用実態調査に基づく疫学的検討.第14回医療情報学連合大会論文集1994 : 239-40.
15) 石倉千代治.Patient medication historyの実際.漢方調剤研究1993;1 (4) : 19-22.
3) The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The 1980 report of the joint national committee on detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1980 ; 140 : 1280-5.
25) Yusuf S. Calcium antagonists in coronary artery disease and hypertension Time for reevaluation? Circulation 1995 ; 92 : 1079-82.
9) Guidelines Sub-Committee (Zanchetti A, Chalmers J, Arakawa K, Gyarfas P, Hamet P, Hansson L, et al.). 1993 guidelines for the management of mild hypertension : memorandum from a WHO/ISH meeting. ISH Hypertension News (Bulle tin of the International Society of Hypertension, June) 1993 ; Special Edition : 3-16.
11) 池田実, 高宮達治, 中村順吉, 宮手義和, 高橋美枝子.高齢者服用薬剤実態調査-高血圧者を中心として-.医薬品相互作用研究1988;12 : 97-102.
12) 山下正秀, 丹野慶紀.高齢高血圧患者の服薬実態調査.医薬品研究1989;13 : 115-21.
13) 小沢政民, 福澄重栄, 加藤正則.高血圧の治療 [第3報] -当院に於ける降圧薬の使用状況と推移-.日本薬学会第115年会講演要旨葉4 1995 : 274.
6) The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the joint national committee on detection, evaluation, and treatment of high blood pressure (JNC V). Arch Intern Med 1993 ; 153 : 154-83.
19) Aoki K, Yoshida T, Katou S, et al. Hypertensive action and increased plasma renin activity by Ca2+ antagonist (nifedipine) in hypertensive patients. Jpn Heart J 1976 ; 17 : 479-84.
22) Psaty BM, Heckbert SR, Koepsell TD, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995 ; 274 : 620-5.
5) The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The 1988 report of the joint national committee on detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1988 ; 148 : 1023-38.
26) News FDA committee rules calcium-channel blockers safe. Lancet 1996 ; 347 : 313.
4) The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The 1984 report of the joint national committee on detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1984 ; 144 : 1045-57.
8) Memorandum from the WHO/ISH. 1986 Guidelines Treatment of Mild Hypertension. Hypertension 1986 ; 8 : 957-70.
References_xml – reference: 22) Psaty BM, Heckbert SR, Koepsell TD, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995 ; 274 : 620-5.
– reference: 10) 厚生省・日本医師会, 編.薬物療法.高血圧診療のてびき.日本医事新報社, 1990 : 24-36
– reference: 15) 石倉千代治.Patient medication historyの実際.漢方調剤研究1993;1 (4) : 19-22.
– reference: 24) Burning JE, Glynn RJ, Hennekens CH. Calcium channel blockers and myocardial infarction ; A Hypothesis formulated but not yet tested. JAMA 1995 ; 274 : 654-5.
– reference: 2) The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Report of the joint national committee on detection, evaluation, and treatment of high blood pressure. JAMA 1977 ; 237 (3) : 255-61.
– reference: 18) Kaplan NM. Clinical Hypertension, 6th ed. 1994 : 198.
– reference: 19) Aoki K, Yoshida T, Katou S, et al. Hypertensive action and increased plasma renin activity by Ca2+ antagonist (nifedipine) in hypertensive patients. Jpn Heart J 1976 ; 17 : 479-84.
– reference: 13) 小沢政民, 福澄重栄, 加藤正則.高血圧の治療 [第3報] -当院に於ける降圧薬の使用状況と推移-.日本薬学会第115年会講演要旨葉4 1995 : 274.
– reference: 17) WHO Collaborating Center for Drug Statistics Methodology. Guidelines for DDD 2nd ed. 1993, Oslo : 1993 : 1-95.
– reference: 6) The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the joint national committee on detection, evaluation, and treatment of high blood pressure (JNC V). Arch Intern Med 1993 ; 153 : 154-83.
– reference: 20) Murakami M, Murakami E, Takekoshi N, et al. Antihypertensive effect of (4-2'-nitrophenyl) -2, 6-dimethyl-1, 4-dihydropyridine-3, 5-dicarbonic acid dimethyl-ester (nifedipine, Bay-a 1040), a new coronary dilator. Jpn Heart J 1972 ; 13 : 128-36.
– reference: 26) News FDA committee rules calcium-channel blockers safe. Lancet 1996 ; 347 : 313.
– reference: 16) Wertheimer AI.Defined daily dose (DDD) system for drug utilization review. Hosp Pharrn 1986 ; 21 : 233-4.
– reference: 25) Yusuf S. Calcium antagonists in coronary artery disease and hypertension Time for reevaluation? Circulation 1995 ; 92 : 1079-82.
– reference: 4) The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The 1984 report of the joint national committee on detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1984 ; 144 : 1045-57.
– reference: 14) 田中照夫, 市原和彦, 西岡豊ほか.四国地区の国立四大学附属病院における降圧薬の服用実態調査に基づく疫学的検討.第14回医療情報学連合大会論文集1994 : 239-40.
– reference: 12) 山下正秀, 丹野慶紀.高齢高血圧患者の服薬実態調査.医薬品研究1989;13 : 115-21.
– reference: 21) 池田正男, 青木久三, 荒川規男ほか. Diltiazem (Herbesser) の本態性高血圧症に対する臨床効果.医学のあゆみ1979;110 : 302-20.
– reference: 11) 池田実, 高宮達治, 中村順吉, 宮手義和, 高橋美枝子.高齢者服用薬剤実態調査-高血圧者を中心として-.医薬品相互作用研究1988;12 : 97-102.
– reference: 7) Report of a WHO Expert Committee. Arterial Hypertension Technical Report Series No. 628. Geneva : WHO 1978.
– reference: 8) Memorandum from the WHO/ISH. 1986 Guidelines Treatment of Mild Hypertension. Hypertension 1986 ; 8 : 957-70.
– reference: 9) Guidelines Sub-Committee (Zanchetti A, Chalmers J, Arakawa K, Gyarfas P, Hamet P, Hansson L, et al.). 1993 guidelines for the management of mild hypertension : memorandum from a WHO/ISH meeting. ISH Hypertension News (Bulle tin of the International Society of Hypertension, June) 1993 ; Special Edition : 3-16.
– reference: 3) The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The 1980 report of the joint national committee on detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1980 ; 140 : 1280-5.
– reference: 23) Furberg CD, Psaty BM, Meyer JV. Nifedipine ; Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995 ; 92 : 1326-31.
– reference: 5) The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The 1988 report of the joint national committee on detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1988 ; 148 : 1023-38.
– reference: 1) 酒井弘憲, 林 邦彦, 折笠秀樹, 楠正.高血圧薬物治療指針の背景と長期臨床比較試験の役割.臨床薬理1995;26 : 637-50.
SSID ssib002484713
ssj0069036
ssib002227601
ssib058494606
ssib002004201
Score 1.3118099
SourceID jstage
SourceType Publisher
StartPage 107
Title 望星薬局における薬歴データを利用した降圧薬の使用実態研究
URI https://www.jstage.jst.go.jp/article/jjpe1996/1/2/1_2_107/_article/-char/ja
Volume 1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 薬剤疫学, 1996/10/31, Vol.1(2), pp.107-115
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1882-790X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0069036
  issn: 1342-0445
  databaseCode: KQ8
  dateStart: 19960101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR1NaxNBdCn1IoL4id_k4PTUxP2Y3Z3B00yyoQhKhRR6C_uVQw61aHqoJ9MiisWDUvzAQr1pUQuCeFL6Y9ak-i98b2az2YigVUiGl5n33rx5b5b33mRm1jAuxymlYRjF1dhK8G_GkFVDmFbVDk9C5rE4dtVF2tdveHML9Nqiuzg1faS0a2mlF9Xiu789V_IvVoU6sCuekj2AZQumUAEw2BdKsDCUf2VjEniE1wmXCmCEN0kApUdEnQQukRbuYwgciBaJkDnARA5wSwE2YbJEBWWDSKqa4OPngKznyLKZA9zGLhgjgpPAJ5wSwUac_REAyJxwTlgDkUFU4Zf60oIFJKBENhTngo-L9UjuEeYqCX0iTGxFgBPplaPqiVEzToRCwxqpWDWIKBYgkaVUsujepImzTP1oEuEqYTh2CpIL5FkmhHaR4ytFCWfcqhhIR4lgohQKzcWxgwKRrQR81T2oUY4JoYUhPrYIwhsjQtAwK6T0x8szuKO7eJRG5CbqAK2hKEABMlA8ij4dwvXgBHyU_GAmHK-aQkj2Zx0qephvouTKHGpXTaov66yluk7lU9xcnPB_pcfcLvmy_HXEeVhk6VO3v3pcByJI9Ljd5RRHX7NqBdnELeb5M9IeIbattq2_pt8eNeJBw3YXsp1DNq6u4RaLm6VkGB2MWQo2bVtv6CqCTYy0Cm8DkTWnHu4h0HGZx031wtBCL_oKVxzAlUnxIRjtQmo22tapIs3WMeNoniJWhBb3uDHVDU8YM_P6jvnV2UprfGTyzmxlpjI_vn1-9aTRGm69Gr7Y_v7s_eDjvaz_Lus_yvpPsrUNqBl--JStP8jWv2Rre9na08HDnf3Nt1n_edbf_vHy8WDrDeBk_d1vX_egfrC7Pby_sf96c3_n8yljoRm06nPV_NUp1S7kNGaV-o7VYWnogcZimiR27ER27Dkd308T0-xQZocRKCgx04iGceKnFk1SGrkQ7VCXRs5pY3rp1lJ6xqgkbgJuOoXEpZNS2_d55MVm6qRx6oQ-6PKscVVrq72s78dpH8TW5_6L-rxxWJ-iwCXRC8Z07_ZKehGShF50Sc2dnxrk4eg
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E6%9C%9B%E6%98%9F%E8%96%AC%E5%B1%80%E3%81%AB%E3%81%8A%E3%81%91%E3%82%8B%E8%96%AC%E6%AD%B4%E3%83%87%E3%83%BC%E3%82%BF%E3%82%92%E5%88%A9%E7%94%A8%E3%81%97%E3%81%9F%E9%99%8D%E5%9C%A7%E8%96%AC%E3%81%AE%E4%BD%BF%E7%94%A8%E5%AE%9F%E6%85%8B%E7%A0%94%E7%A9%B6&rft.jtitle=%E8%96%AC%E5%89%A4%E7%96%AB%E5%AD%A6&rft.au=%E6%B5%9C%E7%94%B0%2C+%E7%9F%A5%E4%B9%85%E9%A6%AC&rft.au=%E6%A5%A0%2C+%E6%AD%A3&rft.au=%E7%9F%B3%E5%80%89%2C+%E5%8D%83%E4%BB%A3%E6%B2%BB&rft.au=%E4%B8%89%E6%BA%9D%2C+%E5%92%8C%E7%94%B7&rft.date=1996&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E8%96%AC%E5%89%A4%E7%96%AB%E5%AD%A6%E4%BC%9A&rft.issn=1342-0445&rft.eissn=1882-790X&rft.volume=1&rft.issue=2&rft.spage=107&rft.epage=115&rft_id=info:doi/10.3820%2Fjjpe1996.1.107&rft.externalDocID=article_jjpe1996_1_2_1_2_107_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1342-0445&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1342-0445&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1342-0445&client=summon